Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Biora Therapeutics, Inc. BIOR

Full chart Compare
Set alert

Price alert · BIOR

All alert types
0.22 USD 0.00 (+0.00%)

Mar 13, 2026, 9:30 AM EDT

0.22 Day range 0.22
0.09 52-week range 7.90
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

-109.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.2×
FY 2018: -27.4×FY 2019: -40.9×FY 2020: -15.4×FY 2021: -11.3×FY 2022: -5.1×FY 2023: -0.2×
FY 2018 5y median -11.3× FY 2023
P/S 5323×
FY 2018: 2.8×FY 2019: 4.2×FY 2020: 4.0×FY 2021: 161×FY 2022: 82.4×FY 2023: 5323×
FY 2018 5y median 82.4× FY 2023
P/B -0.2×
FY 2018: -9.6×FY 2019: -7.2×FY 2020: -2.8×FY 2021: -2.4×FY 2022: -0.2×FY 2023: -0.2×
FY 2018 5y median -2.4× FY 2023
P/FCF -0.4×
FY 2018: -5.1×FY 2019: -5.5×FY 2020: -1.7×FY 2021: -1.2×FY 2022: -0.4×FY 2023: -0.4×
FY 2018 5y median -1.2× FY 2023
EV/EBITDA -0.5×
FY 2018: -3.5×FY 2019: -4.8×FY 2020: -3.4×FY 2021: -1.5×FY 2022: -3.3×FY 2023: -0.5×
FY 2018 5y median -3.3× FY 2023
EV/Sales 13377×
FY 2018: 2.9×FY 2019: 4.5×FY 2020: 4.9×FY 2021: 192×FY 2022: 406×FY 2023: 13377×
FY 2018 5y median 192× FY 2023
FCF Yield -228.2%
FY 2018: -19.8%FY 2019: -18.1%FY 2020: -57.6%FY 2021: -83.8%FY 2022: -259.4%FY 2023: -228.2%
FY 2018 5y median -83.8% FY 2023

Profitability

Gross Margin 100.0%
FY 2018: 28.1%FY 2019: 30.2%FY 2020: -25.7%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%
FY 2018 5y median 100.0% FY 2023
Operating Margin -1678575.0%
FY 2018: -89.3%FY 2019: -97.3%FY 2020: -144.8%FY 2021: -9449.6%FY 2022: -20256.1%FY 2023: -1678575.0%
FY 2018 5y median -9449.6% FY 2023
Net Margin -3102875.0%
FY 2018: -100.9%FY 2019: -102.8%FY 2020: -259.1%FY 2021: -14316.0%FY 2022: -12510.5%FY 2023: -3102875.0%
FY 2018 5y median -12510.5% FY 2023
ROE 122.4%
FY 2018: 349.2%FY 2019: 176.5%FY 2020: 179.9%FY 2021: 210.1%FY 2022: 37.3%FY 2023: 122.4%
FY 2018 5y median 176.5% FY 2023
ROIC 232.3%
FY 2018: -288.7%FY 2019: -5914.1%FY 2020: -96.6%FY 2021: -249.3%FY 2022: -196.9%FY 2023: 232.3%
FY 2018 5y median -196.9% FY 2023
ROA -397.6%
FY 2018: -110.9%FY 2019: -145.5%FY 2020: -124.7%FY 2021: -164.0%FY 2022: -71.3%FY 2023: -397.6%
FY 2018 5y median -145.5% FY 2023

Growth (YoY)

Revenue -98.7%
FY 2018: 0.0%FY 2019: 12.5%FY 2020: -48.4%FY 2021: -98.3%FY 2022: -75.5%FY 2023: -98.7%
FY 2018 FY 2023
Operating Income -8.7%
FY 2018: 0.0%FY 2019: -22.7%FY 2020: 23.2%FY 2021: -9.5%FY 2022: 47.6%FY 2023: -8.7%
FY 2018 FY 2023
EPS (diluted) -1129.7%
FY 2018: 0.0%FY 2019: 33.0%FY 2020: -7.6%FY 2021: 46.2%FY 2022: 86.2%FY 2023: -1129.7%
FY 2018 FY 2023
Free Cash Flow 25.5%
FY 2018: 0.0%FY 2019: -57.0%FY 2020: -55.4%FY 2021: 1.4%FY 2022: 61.3%FY 2023: 25.5%
FY 2018 FY 2023

Financial Health

Current Ratio 0.3×
FY 2018: 1.1×FY 2019: 0.7×FY 2020: 1.7×FY 2021: 1.6×FY 2022: 1.6×FY 2023: 0.3×
FY 2018 5y median 1.6× FY 2023
Quick Ratio 0.3×
FY 2018: 1.0×FY 2019: 0.6×FY 2020: 1.6×FY 2021: 1.6×FY 2022: 1.6×FY 2023: 0.3×
FY 2018 5y median 1.6× FY 2023
Debt / Equity -0.5×
FY 2018: -2.0×FY 2019: -0.9×FY 2020: -1.5×FY 2021: -1.5×FY 2022: -1.3×FY 2023: -0.5×
FY 2018 5y median -1.3× FY 2023
Net Debt / EBITDA -0.3×
FY 2018: -0.2×FY 2019: -0.3×FY 2020: -0.6×FY 2021: -0.2×FY 2022: -2.6×FY 2023: -0.3×
FY 2018 5y median -0.3× FY 2023
Interest Coverage -6.8×
FY 2018: -12.6×FY 2019: -15.2×FY 2020: -10.9×FY 2021: -9.3×FY 2022: -5.6×FY 2023: -6.8×
FY 2018 5y median -9.3× FY 2023

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.7%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: -3.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31